
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Bioeng. Biotechnol. , 08 August 2022
Sec. Synthetic Biology
Volume 10 - 2022 | https://doi.org/10.3389/fbioe.2022.979285
This article is a correction to:
Effective Use of Linear DNA in Cell-Free Expression Systems
A Corrigendum on
Effective use of linear DNA in cell-free expression systems
by McSweeney, M. A., and Styczynski, M. P. (2021) Front. Bioeng. Biotechnol. 9:715328. doi: 10.3389/fbioe.2021.715328
In the original article, there was an error in the Funding statement. The support of the National Science Foundation was omitted. The correct Funding statement appears below.
Funding
“The authors thank the National Institutes of Health (R01-EB022592) and the National Science Foundation (CCF-2007807) for funding support.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cell-free expression, linear expression template, nuclease inhibition, genetic circuits, rapid prototyping, DNA aptamers
Citation: McSweeney MA and Styczynski MP (2022) Corrigendum: Effective use of linear DNA in cell-free expression systems. Front. Bioeng. Biotechnol. 10:979285. doi: 10.3389/fbioe.2022.979285
Received: 27 June 2022; Accepted: 28 June 2022;
Published: 08 August 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 McSweeney and Styczynski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mark P. Styczynski, bWFyay5zdHljenluc2tpQGNoYmUuZ2F0ZWNoLmVkdQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.